Read More Pharma Industry News Klotho Neurosciences begins manufacturing KLTO-202 gene therapy to advance clinical trials in ALS Klotho Neurosciences begins KLTO-202 manufacturing to prepare for ALS clinical trials, with a gene therapy targeting neuroprotection in spinal neurons. byPallavi MadhirajuJuly 1, 2025